Mon panier

SARS-CoV-2 Spike Trimer Protein, His Tag (NB.1.8.1) (MALS verified)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
SPN-S522b-100ug
$472.00
SPN-S522b-1mg (500ug X 2)
$2940.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    Spike, S protein, Spike glycoprotein, S glycoprotein

  • Source

    SARS-CoV-2 Spike Trimer Protein, His Tag (NB.1.8.1) (SPN-S522b) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Pro 1213 (Accession # QHD43416.1 (T19I, R21T, T22N, A27S, S50L, F59S, V127F, G142D, F157S, R158G, G184S, L212I, V213G, L216F, H245N, A264D, I332V, G339H, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, A435S, N440K, V445H, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478I, N481K, E484K, F486P, Q493E, Q498R, N501Y, Y505H, E554K, A570V, D614G, P621S, H655Y, N679K, P681R, N764K, F817P, A892P, A899P, A942P, K986P, V987P, D796Y, S939F, Q954F, N969K, P1143L)). The recombinant protein is expressed from human 293 cells (HEK293) with T4 fibritin trimerization motif and a polyhistidine tag at the C-terminus. Proline substitutions (F817P, A892P, A899P, A942P, K986P, V987P) are introduced to stabilize the trimeric prefusion state of SARS-CoV-2 S protein.

    Predicted N-terminus: Val 16

    Request for sequence

  • Molecular Characterization

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 138.6 kDa. The protein migrates as 80-90 kDa and 100-110 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

    The protein is designed as a trimer.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 0.1 M Sodium citrate with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    Spike protein SDS-PAGE

    SARS-CoV-2 Spike Trimer Protein, His Tag (NB.1.8.1) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Spike protein SEC-MALS

    The purity of SARS-CoV-2 Spike Trimer Protein, His Tag (NB.1.8.1) (Cat. No. SPN-S522b) is more than 85% and the molecular weight of this protein is around 510-560 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     Spike protein ELISA

    Immobilized Human ACE2, Fc Tag (Cat. No. AC2-H5257) at 5 μg/mL (100 μL/well) can bind SARS-CoV-2 Spike Trimer Protein, His Tag (NB.1.8.1) (Cat. No. SPN-S522b) with a linear range of 0.5-31 ng/mL (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

SARS‑CoV‑2 NB.1.8.1 is an Omicron‑descendant variant under monitoring, first detected in early 2025. It carries multiple spike mutations linked to immune escape and shows a growth advantage over co‑circulating BA.2.86/JN.1 lineages2. While currently at low prevalence in many regions, it is spreading in parts of Asia and is expected to rise, though no major increase in disease severity is anticipated.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Coronavirus spike glycoprotein

  • Catégorie:

  • Nombre de médicaments répertoriés:

    15 Détails

  • Nombre de médicaments cliniques:

    88 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte